Levothyroxine Sodium Tablet
Product Images NDC 51655-128

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 128 52 Rev A 03 23)

Label for Levothyroxine Sodium Tablets, USP 137 mcg (0.137 mg) oral tablets. The package contains 30 tablets, labeled Rx Only. It includes storage instructions to keep at 256C (776F) with permitted excursions between 15-306C (59-866F). The label is by Northwind Pharmaceuticals, Indianapolis, IN, and indicates repackaging from Lannett Company, Inc. Additional identifiers include NDC 51655-128-52 and batch details.*

FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Chemical structure of Levothyroxine Sodium showing iodine-substituted aromatic rings connected to an ether linkage and the sodium salt of an amino acid side chain with a hydrate notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.